Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?

Cummins KD, Gill S.

Haematologica. 2019 Jul;104(7):1302-1308. doi: 10.3324/haematol.2018.208751. Epub 2019 Jun 20. No abstract available.

2.

Will CAR T cell therapy have a role in AML? Promises and pitfalls.

Cummins KD, Gill S.

Semin Hematol. 2019 Apr;56(2):155-163. doi: 10.1053/j.seminhematol.2018.08.008. Epub 2018 Aug 29. Review.

PMID:
30926092
3.

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.

Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S.

Cell. 2018 May 31;173(6):1439-1453.e19. doi: 10.1016/j.cell.2018.05.013. Epub 2018 May 31.

4.

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.

Fox LC, Cummins KD, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A.

Blood Adv. 2017 May 15;1(13):802-811. doi: 10.1182/bloodadvances.2016003889. eCollection 2017 May 23.

5.

Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse.

Cummins KD, Gill S.

Leuk Lymphoma. 2018 Jul;59(7):1539-1553. doi: 10.1080/10428194.2017.1375107. Epub 2017 Sep 13. Review.

PMID:
28901790
6.

PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement.

Ong DM, Cummins KD, Pham A, Grigoriadis G.

BMJ Case Rep. 2015 Jul 17;2015. pii: bcr2015211159. doi: 10.1136/bcr-2015-211159.

7.

Numerous Howell-Jolly bodies in a patient with idiopathic splenic calcification.

Cummins KD, Westall GP, Grigoriadis G.

Br J Haematol. 2015 Jun;169(6):767. doi: 10.1111/bjh.13454. Epub 2015 Apr 28. No abstract available.

PMID:
25920798
8.

Isolated iliac vein thrombosis in pregnancy.

Keragala CB, Cummins KD, Goergen SK, Shipp D, Chunilal S.

Intern Med J. 2015 Apr;45(4):460-1. doi: 10.1111/imj.12718. No abstract available.

PMID:
25827515
9.

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia.

Cummins KD, Jane SM, Ninkovic S, Bazargan A, Filshie R, Sutrave G, Hertzberg M, Scott A, Lane S, Yannakou CK, Ritchie D, D'Rozario J, Black J, Bavishi K, Wei A.

Blood Cancer J. 2014 Aug 8;4:e237. doi: 10.1038/bcj.2014.59. No abstract available. Erratum in: Blood Cancer J. 2014;4:e246. Nikovic, S [corrected to Ninkovic, S].

10.

Structural, compositional and electrochemical characterization of Pt-Co oxygen-reduction catalysts.

Axnanda S, Cummins KD, He T, Goodman DW, Soriaga MP.

Chemphyschem. 2010 May 17;11(7):1468-75. doi: 10.1002/cphc.200900924.

PMID:
20394098

Supplemental Content

Loading ...
Support Center